Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis

Bibliographic Details
Main Authors:	Stefano Castellani, Massimo Conese
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417303444

Similar Items

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
by: Massimo Conese, et al.
Published: (2010-01-01)

Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01)

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
by: Giuseppe Fabio Parisi, et al.
Published: (2022-05-01)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
by: Dorina Dobi, et al.
Published: (2023-09-01)

Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
by: Stephanie Chin, et al.
Published: (2019-07-01)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

Functional Consequences of CFTR Interactions in Cystic Fibrosis
by: Yashaswini Ramananda, et al.
Published: (2024-03-01)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
by: Evelina Moliteo, et al.
Published: (2022-08-01)

The Cystic Fibrosis Transmembrane Regulator (CFTR) in the kidney
by: MARCELO M. MORALES, et al.
Published: (2000-09-01)

Strategies to circumvent the CFTR defect in cystic fibrosis
by: Frederic eBecq, et al.
Published: (2013-08-01)

CFTR and Ca2+ signaling in cystic fibrosis
by: Fabrice eAntigny, et al.
Published: (2011-10-01)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
by: Andrea Gramegna, et al.
Published: (2020-08-01)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01)

Nutritional impact of CFTR modulators in children with cystic fibrosis
by: Margaux Gaschignard, et al.
Published: (2023-03-01)

Lived experiences of individuals with cystic fibrosis on CFTR-modulators
by: Annelise Page, et al.
Published: (2022-01-01)

Three-Dimensional Airway Spheroids and Organoids for Cystic Fibrosis Research
by: Onofrio Laselva, et al.
Published: (2021-10-01)

Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis
by: Massimo Conese, et al.
Published: (2021-03-01)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
by: Annalucia Carbone, et al.
Published: (2023-10-01)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020-04-01)

Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis
by: Steven Levitte, et al.
Published: (2023-02-01)

Impact of CFTR modulators on exercise capacity in adolescents with cystic fibrosis
by: Molla Imaduddin Ahmed, et al.
Published: (2024-02-01)

CFTR High Expresser Cells in cystic fibrosis and intestinal diseases
by: Diego Carlos dos Reis, et al.
Published: (2023-03-01)

The effect of CFTR modulators on structural lung disease in cystic fibrosis
by: L. Clara Mok, et al.
Published: (2023-04-01)

Molecular chaperones as targets to circumvent the CFTR defect in cystic fibrosis
by: Rebecca A Chanoux, et al.
Published: (2012-07-01)

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
by: Chaudary N
Published: (2018-12-01)

Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis
by: Haq I, et al.
Published: (2022-02-01)

Predicting CFTR activity with front-runner cystic fibrosis drugs
by: Frédéric Becq
Published: (2015-02-01)

Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium
by: Onofrio Laselva, et al.
Published: (2022-09-01)

Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy.
by: Massimo Conese, et al.
Published: (2014-01-01)

Extracellular Vesicles’ Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPD
by: Sante Di Gioia, et al.
Published: (2022-12-01)

Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease
by: Michelle M. White, et al.
Published: (2017-09-01)

Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis
by: Marco Pedrazzi, et al.
Published: (2021-04-01)

CFTR dysfunction leads to defective bacterial eradication on cystic fibrosis airways
by: Min Wu, et al.
Published: (2024-04-01)

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
by: Francesca Saluzzo, et al.
Published: (2022-04-01)

CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis
by: Jennifer L. Taylor-Cousar
Published: (2020-08-01)

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
by: Isabelle Fajac, et al.
Published: (2021-10-01)

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
by: Lucile Regard, et al.
Published: (2022-05-01)

Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis
by: Danya Muilwijk, et al.
Published: (2022-11-01)

Pregnancy in cystic fibrosis in the era of CFTR modulators: A case series
by: Maria Sionidou, et al.
Published: (2023-03-01)

Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
by: Heledd H Jarosz-Griffiths, et al.
Published: (2020-03-01)